In conclusion, the increase in circulating levels of ET-1 and MMP-9 has been observed in subjects with MetS and might be associated with the underlying causes of the increased risk of cardiovascular diseases, diabetes mellitus and cancer in people with MetS. The gene discussed is EDN1; the disease is cancer.